Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection-Reference-Cited by-同舟云学术

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection

Published:2017 Issue:2 Volume:4 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Guaraldi Giovanni¹,Rossotti Roberto²,Verucchi Gabriella³,Tavio Marcello⁴,Pasulo Luisa⁵,Beghetto Barbara¹,Dolci Giovanni¹,Nardini Giulia¹,Badia Lorenzo³,Magliano Anna⁴,Moioli Maria Cristina²,Puoti Massimo²,Travi Giovanna,Pazzi Annamaria,De Carlis Luciano,Giacomoni Alessandro,Lauterio Andrea,Mangoni Iacopo,Di Sandro Stefano,Ferla Fabio,Fagiuoli Stefano,Colledan Michele,Cologni Giuliana,Di Benedetto Fabrizio,Tarantino Giuseppe,Serra Valentina,Dolci Giovanni,

Affiliation:

1. Infectious Diseases Departments of University of Modena, Italy

2. ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

3. University of Bologna, Italy

4. Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy; and

5. Gastroenterology Department ASST Papa Giovanni XXIII, Bergamo, Italy

Abstract

Abstract This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90% and 100% in those treated with optimal schedules pre- and posttransplant, respectively).

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/4/2/ofx065/33603049/ofx065.pdf

Reference12 articles.

1. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update;Miro;J Hepatol,2015

2. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: is it the waiting list?;Araiz;Liver Transpl,2016

3. Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients;Terrault;Am J Transplant,2014

4. Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease;Charlton;Gastroenterology,2015

5. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy;Campos-Varela;Aliment Pharmacol Ther,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Efficacy and safety of directly acting antiviral drugs in HCV patients with HIV in liver transplantation: A meta-analysis;Decoding Infection and Transmission;2023

3. Review: Evaluation and Management of the HIV/HCV Co-Infected Kidney or Liver Transplant Candidate;CURR TREAT OPT INFEC;2020

4. Sustained virological response with 16‐week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post‐transplant severe HCV recurrence in HIV;Transplant Infectious Disease;2019-09-15

5. The Use of Grafts from HCV+ Patients in Transplantation: Are we There Yet?;Current Hepatology Reports;2019-05-02